FASSIHI REZA 4/A
4/A · SCOLR Pharma, Inc. · Filed Aug 28, 2006
Insider Transaction Report
Form 4/AAmended
FASSIHI REZA
Director
Transactions
- Exercise/Conversion
Common Stock
2006-08-08$1.05/sh+50,000$52,500→ 50,067 total
Footnotes (1)
- [F1]Amended to correct amount of securities beneficially owned.